Bio-Solutions Corp. Announces its First Distribution Agreement of NutraAnimalTM With Jupiter Agro-Biotech Inc., for the Canadian Market
MONTREAL, CANADA--(Marketwire - Nov. 3, 2009) - Bio-Solutions Corp. (OTCBB:BISU), announces that this first distribution agreement represents a minimum of 350,000$ in revenues for the first year with potential revenues of one million in the next twelve months in the Canadian poultry market. Jupiter Agro-Biotech is a company specialized in feed supplements for livestock and of the distribution of these supplements in Canada. "Jupiter Agro-Biotech Inc. is one of the major Canadian distributors in the field" indicates CEO, Dr. Gilles Chaumillon. The American poultry market in itself represents multi million dollars in revenues for Bio-Solutions Corp, at maturity.
NutraAnimalTM is an active organic dietary supplement which improves the chicken's anti-oxidant defence system and decrease oxidative stress, allowing for more sustainable growth. This product can also be used as supplement for large animal to achieve the same benefits. With present experiments being conducted, Bio-Solutions Corp will be able to evaluate the advantages and the increase in output that the product may possibly offer. Unquestionably, favourable results will offer this product a colossal market opportunity in a large market. "The use of more potent organic molecules or innovative complex than those currently on the market, with a better safety profile have an immense market potential for humans, in the veterinary field, or for animal care as well", added Dr. Gilles Chaumillon, CEO.
Bio-Solutions Corp is a biotechnology company specializing in veterinary care and organic dietary supplement for livestock and domestic animals. Jupiter Agro-biotech, based in Saint-Hyacinthe, Quebec, is one of the major Canadian distributors of food supplements for livestock breeding and domestic pet care products.
For more information on Bio-Solutions Corp. and its products, please visit the company's website at www.bio-solutionscorp.com
Forward-Looking Statements
This press release contains forward-looking statements made pursuant to the safe harbour provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Bio-Solutions' actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of studies, the ability of the Company to take advantage of business opportunities in the biotechnology industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements and disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments, except if we are requested by a governmental authority or applicable law.
For more information, please contact
Investor & Public Relations:
Adrian McKenzie
561-654-5722
pbdcllc@gmail.com
DISCLAIMER: I am not a registered investment adviser or broker/dealer. I make no commitment that the purchase of any securities I mention are advisable for any person or that an investment in such securities will be profitable. In general, given the natur